Global Pathogen Surveillance Alliance (GPSA): Tiered Access Data Platform + 48-Hour Equity Rule
Description
Establish a Global Pathogen Surveillance Alliance — a binding multilateral agreement establishing standards for pathogen detection, sequencing, and data sharing during outbreaks. The system uses a tiered-access model: (1) Metadata Tier (Geographic, temporal, species, pathogen genus) — universally available in real-time, no restrictions.
Enables global detection of novel pathogens without exposing sequence data. (2) Sequence Tier (Full genomic sequences) — available to credentialed researchers (university affiliation, institutional review) with a 48-hour embargo for safety review. This window allows experts to assess whether the sequence contains concerning gain-of-function features before universal release.
(3) Alert Tier (Designated variants of concern) — pathogen sequences flagged by consensus expert review as requiring special attention (high transmissibility, vaccine escape, etc.) — released with context and epidemiological interpretation, not in isolation.
The GPSA is housed in WHO and funded through a binding agreement similar to the Biological Weapons Convention, with compliance monitored via voluntary audit and peer accountability. All participating countries commit to universal sequencing of novel pathogens (target: 100 genomes per confirmed novel pathogen within 30 days).
Implementation Pathway
Phase 1 (2026–2027)
- • GPSA charter negotiated and signed by 50+ countries
- • Tiered-access metadata platform operational
- • Credentialing system for researcher access established
Phase 2 (2027–2029)
- • 100 countries participating in universal sequencing program
- • 48-hour review and release process operational
- • Integration with national surveillance systems in 40 countries
Phase 3 (2029+)
- • GPSA becomes the de facto global standard for pathogen surveillance data
- • 90% of novel pathogens sequenced and shared within 30 days globally
- • Zero pandemic detection delays attributable to surveillance gaps
Required Resources
Impact Analysis
Overall Net Impact
Combined analysis across all timeframes
Short-term
0-2 years
No benefits identified
No harms identified
Mid-term
3-10 years
No benefits identified
No harms identified
Long-term
10+ years
No benefits identified
No harms identified